换一批Polymorphism of TS 3'-UTR predicts survival of Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.
第一作者：
J,Gao
第一单位：
Department of GI Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, No. 52, Fucheng Road, Haidian District, Beijing, 100142, China.
作者：
医学主题词
3'非翻译区(3' Untranslated Regions);成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);脱氧胞苷(Deoxycytidine);女(雌)性(Female);氟尿嘧啶(Fluorouracil);人类(Humans);男(雄)性(Male);亚甲基四氢叶酸还原酶(NADPH)(Methylenetetrahydrofolate Reductase (NADPH2));中年人(Middle Aged);紫杉酚(Paclitaxel);多态现象, 遗传(Polymorphism, Genetic);胃肿瘤(Stomach Neoplasms);存活率分析(Survival Analysis);胸苷酸合酶(Thymidylate Synthase)
DOI
10.1007/s12094-012-0979-8
PMID
23263912
发布时间
2022-12-07
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
